Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (30821)
All Articles published online
|
Publishing Process of This Article
|
Aug 12, 2014 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Translational Medicine
ISSN
2220-6132
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qian Y, Wang X, Chen X. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World J Transl Med 2014; 3(2): 37-57 [DOI: 10.5528/wjtm.v3.i2.37] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v3/i2/37.htm |
| Number | Citing Articles |
| 1 |
Byoung Hyuck Kim, Ji Hyun Chang. Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49928-x
|
| 2 |
Pratik Shriwas, Dennis Roberts, Yunsheng Li, Liyi Wang, Yanrong Qian, Stephen Bergmeier, Jennifer Hines, Subhodip Adhicary, Corinne Nielsen, Xiaozhuo Chen. A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism. Cancer & Metabolism 2021; 9(1) doi: 10.1186/s40170-021-00248-7
|
| 3 |
Nada Oršolić, Maja Jazvinšćak Jembrek. Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer. International Journal of Molecular Sciences 2022; 23(18): 10479 doi: 10.3390/ijms231810479
|
| 4 |
Mahsa Eshkevar Vakili, Fateme Nezhad Shah Mohammadi, Mohammad Reza Ataollahi, Keivan Shams, Kari K. Eklund, Gholamreza Daryabor, Kurosh Kalantar. Targeting T Cell Metabolism as a Novel Approach for Treatment of MS:
With a Focus on PFKFB3 Inhibitors. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(4): 417 doi: 10.2174/1871530322666220921160930
|
| 5 |
Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong, Lisa A. Porter. Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors. Journal of Nuclear Medicine 2020; 61(6): 904 doi: 10.2967/jnumed.119.231068
|
| 6 |
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, Wukun Liu, Hanjing Peng, Yuefan Wang, A. V. Subba Rao, Ruo‐jing Li, Xue Ying, Preethi Korangath, Maria V. Liberti, Yingjun Li, Yongmei Xie, Sam Y. Hong, Cordelia Schiene‐Fischer, Gunter Fischer, Jason W. Locasale, Saraswati Sukumar, Heng Zhu, Jun O. Liu. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays. Angewandte Chemie International Edition 2019; 58(48): 17158 doi: 10.1002/anie.201905578
|
| 7 |
Shabnam Heydarzadeh, Ali Asghar Moshtaghie, Maryam Daneshpour, Mehdi Hedayati. Hypothyroidism - New Aspects of an Old Disease. 2022; doi: 10.5772/intechopen.101937
|
| 8 |
Narayan Sugandha, Lovika Mittal, Amit Awasthi, Shailendra Asthana. Cancer Cell Metabolism: A Potential Target for Cancer Therapy. 2020; : 103 doi: 10.1007/978-981-15-1991-8_8
|
| 9 |
Pratik Shriwas, Xiaozhuo Chen, A. Douglas Kinghorn, Yulin Ren. Plant‐derived glucose transport inhibitors with potential antitumor activity. Phytotherapy Research 2020; 34(5): 1027 doi: 10.1002/ptr.6587
|
| 10 |
Hamid Aria, Marzieh Rezaei, Shima Nazem, Abdolreza Daraei, Ghasem Nikfar, Behnam Mansoori, Maryam Bahmanyar, Alireza Tavassoli, Mohammad Kazem Vakil, Yaser Mansoori. Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.947885
|
| 11 |
Tomoyuki Furuta, Yuya Mizukami, Lisa Asano, Kenjiro Kotake, Slava Ziegler, Hiroki Yoshida, Mizuki Watanabe, Shin-ichi Sato, Herbert Waldmann, Makiya Nishikawa, Motonari Uesugi. Nutrient-Based Chemical Library as a Source of Energy Metabolism Modulators. ACS Chemical Biology 2019; 14(9): 1860 doi: 10.1021/acschembio.9b00444
|
| 12 |
Farzaneh Beygi, Azar Mostoufi, Ayyub Mojaddami. Novel Hydrazone Derivatives of 3‐Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies. Chemistry & Biodiversity 2022; 19(6) doi: 10.1002/cbdv.202100754
|
| 13 |
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps. Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 2021; 71(2): 107 doi: 10.3322/caac.21652
|
| 14 |
Yulin Ren, Qingwei Tan, Kimberly Heath, Sijin Wu, James R. Wilson, Jinhong Ren, Pratik Shriwas, Chunhua Yuan, Tran Ngoc Ninh, Hee-Byung Chai, Xiaozhuo Chen, Djaja D. Soejarto, Michael E. Johnson, Xiaolin Cheng, Joanna E. Burdette, A. Douglas Kinghorn. Cytotoxic and non-cytotoxic cardiac glycosides isolated from the combined flowers, leaves, and twigs of Streblus asper. Bioorganic & Medicinal Chemistry 2020; 28(4): 115301 doi: 10.1016/j.bmc.2019.115301
|
| 15 |
Yulin Ren, Hennrique T. Ribas, Kimberly Heath, Sijin Wu, Jinhong Ren, Pratik Shriwas, Xiaozhuo Chen, Michael E. Johnson, Xiaolin Cheng, Joanna E. Burdette, A. Douglas Kinghorn. Na+/K+-ATPase-Targeted Cytotoxicity of (+)-Digoxin and Several Semisynthetic Derivatives. Journal of Natural Products 2020; 83(3): 638 doi: 10.1021/acs.jnatprod.9b01060
|
| 16 |
Ana M. Barbosa, Fátima Martel. Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds. Cancers 2020; 12(1): 154 doi: 10.3390/cancers12010154
|
| 17 |
Anna Choromańska, Jolanta Saczko, Sandra Łubińska, Anna Szewczyk, Julita Kulbacka. WITHDRAWN: Mechanisms of antimelanoma effect of oat β-glucan supported by electroporation. Bioelectrochemistry 2018; doi: 10.1016/j.bioelechem.2018.01.003
|
| 18 |
Shabnam Heydarzadeh, Ali Asghar Moshtaghie, Maryam Daneshpoor, Mehdi Hedayati. Regulators of glucose uptake in thyroid cancer cell lines. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00586-x
|
| 19 |
Hweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, Mai Chan Lau, Bernett Lee, Jasmine Tan, Cindy Phua, Florida Toh, Yvonne Nga, Wei Hseun Yeap, Baptiste Janela, Dilip Kumar, Hao Chen, Joe Yeong, Justin A. Kenkel, Angela Pang, Diana Lim, Han Chong Toh, Tony Lim Kiat Hon, Christopher I. Johnson, Hanif Javanmard Khameneh, Alessandra Mortellaro, Edgar G. Engleman, Olaf Rotzschke, Florent Ginhoux, Jean-Pierre Abastado, Jinmiao Chen, Siew Cheng Wong. Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(12): 6350 doi: 10.3390/ijms22126350
|
| 20 |
Daniel R. Schmidt, Rutulkumar Patel, David G. Kirsch, Caroline A. Lewis, Matthew G. Vander Heiden, Jason W. Locasale. Metabolomics in cancer research and emerging applications in clinical oncology. CA: A Cancer Journal for Clinicians 2021; 71(4): 333 doi: 10.3322/caac.21670
|
| 21 |
Monika Pliszka, Leszek Szablewski. Glucose Transporters as a Target for Anticancer Therapy. Cancers 2021; 13(16): 4184 doi: 10.3390/cancers13164184
|
| 22 |
Vasilij Koshkin, Laurie E. Ailles, Geoffrey Liu, Sergey N. Krylov. Metabolic Suppression of a Drug‐Resistant Subpopulation in Cancer Spheroid Cells. Journal of Cellular Biochemistry 2016; 117(1): 59 doi: 10.1002/jcb.25247
|
| 23 |
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, Wukun Liu, Hanjing Peng, Yuefan Wang, A. V. Subba Rao, Ruo‐jing Li, Xue Ying, Preethi Korangath, Maria V. Liberti, Yingjun Li, Yongmei Xie, Sam Y. Hong, Cordelia Schiene‐Fischer, Gunter Fischer, Jason W. Locasale, Saraswati Sukumar, Heng Zhu, Jun O. Liu. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays. Angewandte Chemie 2019; 131(48): 17318 doi: 10.1002/ange.201905578
|
| 24 |
Beatriz Bueschbell, Ana Beatriz Caniceiro, Pedro M.S. Suzano, Miguel Machuqueiro, Nícia Rosário-Ferreira, Irina S. Moreira. Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer. Drug Resistance Updates 2022; 60: 100811 doi: 10.1016/j.drup.2022.100811
|
| 25 |
Subodh Kumar, Gitika Batra, Seema Bansal, Praisy K. Prabha, Hardeep Kaur, Ajay Prakash, Anurag Kuhad, Bikash Medhi. Biomarkers in Cancer Detection and Monitoring of Therapeutics. 2024; : 297 doi: 10.1016/B978-0-323-95116-6.00016-5
|
| 26 |
Sindhuri Pragallapati, Ravikanth Manyam. Glucose transporter 1 in health and disease. Journal of Oral and Maxillofacial Pathology 2019; 23(3): 443 doi: 10.4103/jomfp.JOMFP_22_18
|
| 27 |
Izabela Nawrot-Hadzik, Adam Matkowski, Magdalena Fast, Anna Choromańska. The combination of pro-oxidative acting vanicosides and GLUT1 inhibitor (WZB117) exerts a synergistic cytotoxic effect against melanoma cells. Fitoterapia 2023; 171: 105702 doi: 10.1016/j.fitote.2023.105702
|
| 28 |
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, Vadim Pokrovsky, Jun-yong Choe, C.S. Ramaa. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188457 doi: 10.1016/j.bbcan.2020.188457
|
| 29 |
Ana S. Nunes, Andreia S. Barros, Elisabete C. Costa, André F. Moreira, Ilídio J. Correia. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnology and Bioengineering 2019; 116(1): 206 doi: 10.1002/bit.26845
|
| 30 |
Yu-Liang Li, Hao-Cheng Weng, Jui-Ling Hsu, Shu-Wha Lin, Jih-Hwa Guh, Lih-Ching Hsu. The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01311
|